New findings led by researchers at the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) show that regional trial eligibility screening holds the promise of substantially increasing the number of patients who are found eligible to enroll in cancer clinical trials.
According to a new survey, half of Lesbian, Gay, Bisexual, Transgender, and Queer/Questioning (LGBTQ+) cancer patients and survivors report they are concerned they may face discrimination in a health care setting. More than one-third have experienced discrimination in a health care setting due to their sexual orientation or gender identity, and 75% of those who say they experienced discrimination feel it impacted their health care.
The American Cancer Society Cancer Action Network (ACS CAN) submitted comments today supporting the U.S. Department of Health and Human Services’ proposed rule to expand federal insurance coverage eligibility to Deferred Action for Childhood Arrivals (DACA) recipients.
Rhode Island lawmakers have taken the first step towards ensuring cancer patients and others with chronic disease are protected from excessive prescription drug costs.
TRENTON, NJ – DECEMBER 19, 2022 – Earlier today, the New Jersey State Senate joined its Assembly counterpart in approving legislation that seeks to remove financial barriers to lifesaving colorectal cancer screening.
As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes.
ALBANY, NY – DECEMBER 15, 2022 – The costs of being diagnosed with cancer last long after the diagnosis and initial treatment putting cancer survivors at increased risk for lifelong financial hardship, according to a new report from the American Cancer Society Ca
ALBANY, NY – DECEMBER 12, 2022 – The American Cancer Society Cancer Action Network (ACS CAN) and Santa Clause join children throughout New York in preparing a Christmas wish list, to be delivered tomorrow by Old Saint Nick to legislators in Albany.
Governor Gavin Newsom vetoed legislation that aimed to enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for cancer patients.
A new Survivor Views survey from the American Cancer Society Cancer Action Network shows that while copay assistance programs can help cancer patients afford the medications they need, some aren’t able to apply them to their health insurance deductible or other out-of-pocket requirements, which can create a barrier to care.